We are live on ! Find out more
SGAR

iPath Pure Beta Sugar ETN

Delisted

SGAR was delisted on the 11th of April, 2018.

2 hedge funds and large institutions have $39K invested in iPath Pure Beta Sugar ETN in 2014 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding

Funds holding: 12 (+1)

11% more capital invested

Capital invested by funds: $35K → $39K (+$4K)

Holders
2
Holders Change
+1
Holders Change %
+100%
% of All Funds
0.06%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
1
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

Rank Fund Capital Flow
1
U
UBS
Switzerland
+$10.9K
2
TRCT
Tower Research Capital (TRC)
New York
+$32

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
U
1
UBS
Switzerland
$39K +$10.9K +339 +35%
TRCT
2
Tower Research Capital (TRC)
New York
+$32 +1 New

SGAR Hedge Fund Activity: Q3 2014 in Review

2 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in iPath Pure Beta Sugar ETN (SGAR) for Q3 2014, worth a combined $39K — up 11% from $35K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new SGAR positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.

The largest buyer was UBS, adding an estimated $10.9K.

  • 2 institutional investors held iPath Pure Beta Sugar ETN (SGAR) as of Q3 2014, up from 1 in Q2 2014.
  • Funds reported $39K of iPath Pure Beta Sugar ETN stock for Q3 2014, up 11% quarter-over-quarter.
  • 1 fund opened new iPath Pure Beta Sugar ETN positions in Q3 2014 and 0 closed out, a net change of +1 holder.
  • The largest iPath Pure Beta Sugar ETN buyer in Q3 2014 was UBS, an estimated $10.9K added.

Based on aggregated 13F filings for Q3 2014.